After getting engaged, the only words journalist Mrinali Dhembla expected to hear were “I do.” Instead, she was told, “You have cancer.” “When I first heard the words, ‘You have cancer,’ I was ...

Aggregating ‘negative’ immunotherapy trials can uncover reproducible immune perturbations that are missed in single studies, reframing lack of clinical benefit as potentially informative biologic ...

Cancer treatment has changed dramatically over the past decade. What was once dominated by extensive surgeries followed by aggressive chemotherapy and radiation has now evolved into a more balanced, ...

Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer survival and potential cures. Immunotherapy is changing treatment ...

The combination of belzutifan plus lenvatinib significantly improved outcomes for patients with clear cell renal cell carcinoma who progressed following immunotherapy compared with cabozantinib ...

Dispatch Bio has unveiled with $216 million and the lofty goal of creating a universal treatment for solid tumors using a new immunotherapy approach. The biotech was formed around the concept of ...

Aug. 4 (UPI) --Findings from a study in mice suggest that using a common artificial sweetener, sucralose, could hamper certain immunotherapy treatments in cancer patients. However, for folks reluctant ...

Trilaciclib protects bone marrow before SCLC chemotherapy, sharply reducing neutropenia, anemia, and thrombocytopenia, improving fatigue and keeping treatment on schedule without weakening tumor kill.

Post-treatment lung health is a longitudinal survivorship issue; nonregenerative parenchymal loss, radiation fibrosis, and ...

DOCTOR, SEVERAL NEW TREATMENTS ARE REVOLUTIONIZING THE FIGHT AGAINST BREAST CANCER AND CHIEF OF MEDICAL ONCOLOGY AT MERCY MEDICAL CENTER, DOCTOR DAVID REISBERG IS JOINING US NOW WITH SOME MORE ...